Lecture 3 Flashcards
ADME
Absorption
Distribution
Metabolism
Excretion
Study of how a body influences a drug
Pharmacokinetics
________ is a breakdown of the processes which affect a drug molecule
ADME
The movement of a drug from the site of administration into the bloodstream
Drugs enter the bloodstream for the purpose of traveling to their target tissues
Absorption
Administration route
Cell membrane permeability
Drug formulation
Physiology: gastric emptying, surface area, temperature
Factors that affect Absorption
non-invasive, good for repeated dosing, safety
Subject to first-pass metabolism
Prodrugs
Absorption: ORAL ROUTE
Intravenous: rapid
Subcutaneous: slower
Intramuscular: larger volumes, slow-release formulas
Routes: Parenteral Routes
Localized
Mucous membranes? Rapid uptake
Routes: Topical
Sustained release
Can be irritating
Routes: Transdermal
Rapid, efficient
Initial localization to pulmonary system
Routes: Inhaled
When it goes into the stomach first and then the liver it’s called
First pass
How much of the drug gets absorbed
Usually described as a percentage
Oral? IV?
Bioavailability
Two drugs that have the same bioavailability and same concentration of active ingredient
Bioequivalents (generic vs brand)
Drug molecules can cross a barrier passively or actively
Active transport
Passive diffusion
Movement across membranes
- molecule size
- lipophinicity
- drug ionization
Membrane permeability
Smaller drugs are absorbed faster than larger drugs
Molecule size
Lipophilic = increased absorption
Lipophilicity
Want drugs to be neutral when they are absorbed, not ionized
A basic drug in an acidic environment will not absorb well
An acidic drug in a basic environment will not absorb well
Drug ionization
Drugs are designed and formulated with the pH of the enteral environment in mind
Weakly acidic drugs are meant to be absorbed in the stomach
Likewise, weakly basic drugs are meant to be absorbed in the intestine (alkaline environment)
Think: neutral is better than ionized, and the pH of the environment surrounding the drug molecule impacts it’s charge
How do we know whether a drug is intended for stomach or intestinal absorption?
Ionization
Coatings
Buffered medications
Hydrogels
Sustained v. controlled release
Absorption: drug formulation
Enteric coating (“EC”)
Prevents drug from dissolving in stomach
Enteric coated tabs absorb in the intestine
Therefore, we do not EVER crush or dissolve an enteric coated tab prior to administration! (no GT tubes, no pudding)
Coatings
Drug contains ions to decrease gastric acidity
Buffered Medication
drug released over period of time
Controlled release
drug released at a constant rate over time
Sustained release (“SR”)
high dose intended to release over extended period.
Crushing, chewing, splitting or opening immediately releases the entire dose
Extended-release (“XR”) formulations
_________ drugs cannot be administered PO
Example: InsulinProtein would be digested by the stomach and rendered useless. That is why we inject insulin.
Protein-based
some drugs may have unpleasant effect on oral cavity (bitter taste, stain teeth, irritate mucosa). Any drug with an oral cavity effect may have a more palatable alternative (e.g: sweetened liquid) so ask pharmacy!
Other considerations for crushing
Gastric emptying
Blood flow
Surface area
Body temperature
Psysiologic and other factors that affect absorpotion
Fatty foods delay emptying
Some drugs can decrease motility
Nursing implication for this?
Gastric emptying
Increased blood flow = increased absorption
Blood flow
Can affect topicals
Body Temperature
Transport of a drug by the bloodstream to its site of action
Distribution
Blood flow to target tissue
Drug solubility (lipophilic/hydophobic)
Drug-Protein binding
Special physiologic barriers
Blood-Brain Barrier
Fetal circulation
Factors affecting distribution
More blood flow = more drug reaching target tissue
Drugs distribute first to areas with ++ blood supply
Blood Flow to target tissue
Lipid-soluble cross cell membranes more readily
Drugs in their active form are usually lipophilic
Question for thinking! – equal amounts of lipid-soluble drug and water-soluble drug – which one will have higher plasma concentration?
Solubility
Drugs will bind to proteins in the bloodstream (albumin)
Only unbound drug molecules can freely distribute – “active”
low albumin levels = risk for toxicity
Drug-protein binding
two medications that are highly protein-bound may “compete” for binding sites on the albumin.
Protein binding site competition
Creates more free, unbound drug = unpredictable drug response
This is called a ______ interaction
drug-drug
when the presence of one drug decreases or increases the action of another drug administered concurrently
Drug to Drug Interaction
Does not contain capillary pores
Protects brain from pathogens and toxins
Only lipid-soluble drugs able to cross
Not fully developed in neonates
Inflammation can increase permeability
Blood-brain barrier
Prevents harmful substances from passing from mother’s blood stream to fetus
Permeability of barrier changes during pregnancy
However, some drugs can cross (alcohol, cocaine, caffeine, some prescription meds)
Pregnancy categories for drugs
Must consider if patient is of childbearing age prior to prescribing a drug.
Fetal-placental barrier
Also called Biotransformation
Metabolism
________ alteration of a drug into:
Inactive metabolite
A more soluble compound
A more potent metabolite (conversion from a Prodrug)
A less active metabolite
Biochemical
Large class of enzymes, known as microsomal enzymes
Targeted against lipophilic medications (most meds)
Hepatic Enzymes: Cytochrome P450 System
Drugs that are metabolic targets of specific enzymes are said to be _______ of those enzymes
substrates
So, lipid-soluble meds are “substrates” of the _____ enzymes
CYP450
Lots of drugs ______ the CYP450 system – results in toxicity
Some substances _______ the CYP450 system – “inducers”
inhibit; activate
CYP450 _____ drugs
metabolizes
genetics, presence of other drugs, certain foods
Influence inhibition and induction
Inducer
Other inducers: caffeine, chronic alcohol, chronic tobacco
St. John’s Wort (NHP)
Inhibitor
Grapefruit Juice
CYP450 System responsible for _______ effect!
first-pass
__________ affects CYP
Nutritional status
Metabolic pathway competition: 2 drugs competing for the same enzyme? -> another ______________
drug-drug interaction
Structural change = _______ change
functional
Metabolite could be __________ (because metabolism inactivated the drug)
non-functional
Metabolite could be __________ (because the metabolism activated the prodrug)
functional
Codeine is a prodrug for
morphine
Some metabolites are _______ to the liver
toxic
Tylenol metabolites – _______, __________
*when used appropriately – Tylenol has high safety profile!
liver, kidneys
Infants: immature CYP system
Elderly: enzyme activity reduced
Genetic polymorphisms
Lifespan: metabolism
Elimination of drugs from the body
- Kidney
- Pulmonary
- Glandular
- Intestinal/fecal
Excretion
_________ affects blood concentration
Inverse -> more excretion = lower blood concentration
Excretion rate
May come to kidney as metabolites, or in active form
Metabolized drugs are easier to excrete (due to polarization + water solubility)
Passive diffusion in the glomerulus
Many drugs stay in the urine and do not get resorbed
Changes in urine pH can influence whether a molecule gets reabsorbed
Kidney damage = reduced renal excretion -> clinical implication?
Renal excretion
Gases and volatile liquids
Most drugs excreted unmetabolized
Excretion rate affected by resp rate and blood flow
Pulmonary Excretion
Sweat, saliva, breast milk, seminal fluid
Water-soluble molecules
Glandular Excretion
“biliary excretion”
Enterohepatic recirculation
Intestinal Excretion
Pharmacotherapy goals
Onset of action
Duration of action
Peak effect
Peak level
Half-life
Steady state
Time-response relationships
Maintain drug at concentration that produces therapeutic response
Pharmacotherapy goals
time required for a drug to elicit therapeutic response
Onset of action
time period during which drug is in therapeutic range
Duration of action
time required to reach maximal therapeutic response
Corresponds physiologically to increasing drug concentration at site of action
Not to be confused with peak level
Peak effect
_________ = highest blood level; Trough Level = lowest blood level
Peak Level
Time required for serum levels to be reduced by one half (50%)
Represents the rate of elimination
5 half-lives to reduce by 97%
Clinically useful to determine steady-state, estimates duration of action
Shorter half life – given more frequently (morphine half life 3 hrs)
Steady State
Physiological state in which the amount of drug removed via elimination = the amount of drug absorbed with each dose
Half-life
__________ = consistent levels that correlate with maximum therapeutic benefits
Steady state is achieved in about 5 half-lives worth of time for the drug
Steady state
Topical (direct app. to skin)
Optic
Otic
Vaginal
Inhaled
Nebules
Rectal
Medication adminstration
topical administration is often used to produce an effect at the place it is applied
Unintended adverse effects usually due to drug being absorbed into circulation
Local effects
some drugs given topically are absorbed into blood to produce effects throughout the body
Slow release preparations
Consider the pharmacokinetic principle of “Absorption”
Systemic effects
Can be formulated and applied to achieve local or systemic effects
Application is directly to the site of intended action
Fewer adverse effects than enteral or parenteral routes
No first pass metabolism or digestion by liver enzymes
For some routes, patient does not have to be conscious
Advantages of Topical
Can be irritating to site of administration
Local application can produce systemic adverse effects
Disadvantages of Topical
Sublingual*
Buccal*
Lotion, ointment, cream, powder, foam, patch, disc
Direct application to skin or mucosa
Direct application to mucous membrane
Inhalation of medicated aerosol spray
Inhalation of dry powder medication
Inserting medication into a body cavity
“Topical” covers many forms of drug
Cleansed + Dried, hairless
Assess prior to application (elderly – thin skin)
No open areas (unless specified for wound – sterile technique!)
Skin Prep
Skip prep
Use gloves/applicators
Thicknss of application
Skin Applications
Lotions + ointments
spread evenly
rub in firmly
Liniment
If applying _______, have pt turn their head to avoid accidental inhalation
powder
a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream.
Transdermal patch
Nasal spray, drop, or tampon
Intransal route
easy, avoid first-pass
Intranasal advantages
Cilia damage, mucosal irritation, absorption may be affected by mucous secretions
Intranasal disadvantages
Spray: tilt head back, to the side being treated
Drops: depends on target area
Remain in position 5 minutes
Intranasl positioning
Sympathomimetic medications
Long-term decongestant use
Intranasal
tilt the head backward
Instilling Nasal Drops: Posterior Pharynx
place head gently over edge of bed OR pillow under shoulders and tilt head back
Nasal drops: Ethmoid or Sphenoid sinus
tilt head back and turn towards the side to be treated
Nasal drops: Frontal or Maxillary
Forms: drops, ointments, Intraocular disc
Opathalmic
Gently roll container
Instruct patient to look up
Non-dominant hand: use cotton ball, gently pull lower lid open to expose conjunctival sac
Dominant hand: rest on patient forehead, hold dropper 1-2 cm above conjunctival sac
Do not touch dropper to the eye
Do not touch dropper with your fingers
Never apply gtts to the cornea; drops should go into the conjunctival sac
If you miss (patient moved or blinks), repeat procedure
Drops before ointment
Instilling drops